It has been reported to be highly expressed in breast cancer and positively correlated with the progression of breast cancer by activating the Wnt/β-catenin pathway or enhancing the activity of Twist and estrogen receptor α (ERα) 23-25. Here, ESR1 is linked to breast cancer.